Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Circulation
|
February 11, 2009
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial
Inder S Anand, Peter Carson, Elizabeth Galle, et al.
JACC. Heart Failure
|
March 7, 2023
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial
Peter Carson, John R Teerlink, Michel Komajda, et al.
Journal of Cardiac Failure
|
August 30, 2011
Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure
William T Abraham, Koonlawee Nademanee, Kent Volosin, et al.
Circulation
|
August 30, 2021
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
Milton Packer, Javed Butler, Faiez Zannad, et al.
JACC. Heart Failure
|
February 3, 2025
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved Trial
Peter Carson, John R Teerlink, Michel Komajda, et al.
American Heart Journal
|
February 15, 2011
A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure
Alan Kadish, Koonlawee Nademanee, Kent Volosin, et al.
Circulation
|
October 21, 2020
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial
Milton Packer, Stefan D Anker, Javed Butler, et al.
The American Journal of Medicine
|
January 3, 2015
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure
Vikas Bhatia, Navkaranbir S Bajaj, Kumar Sanam, et al.
American Heart Journal
|
May 4, 2010
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program
Christopher M O'Connor, Alan B Miller, John E A Blair, et al.
JACC. Heart Failure
|
May 11, 2020
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials
Jonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Circulation
|
February 11, 2009
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial
Inder S Anand, Peter Carson, Elizabeth Galle, et al.
JACC. Heart Failure
|
March 7, 2023
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial
Peter Carson, John R Teerlink, Michel Komajda, et al.
Journal of Cardiac Failure
|
August 30, 2011
Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure
William T Abraham, Koonlawee Nademanee, Kent Volosin, et al.
Circulation
|
August 30, 2021
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
Milton Packer, Javed Butler, Faiez Zannad, et al.
JACC. Heart Failure
|
February 3, 2025
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved Trial
Peter Carson, John R Teerlink, Michel Komajda, et al.
American Heart Journal
|
February 15, 2011
A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure
Alan Kadish, Koonlawee Nademanee, Kent Volosin, et al.
Circulation
|
October 21, 2020
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial
Milton Packer, Stefan D Anker, Javed Butler, et al.
The American Journal of Medicine
|
January 3, 2015
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure
Vikas Bhatia, Navkaranbir S Bajaj, Kumar Sanam, et al.
American Heart Journal
|
May 4, 2010
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program
Christopher M O'Connor, Alan B Miller, John E A Blair, et al.
JACC. Heart Failure
|
May 11, 2020
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials
Jonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Page
of 5